SCHEMBL19062204

SCHEMBL19062204

Cc1nn(-c2ccnc3c2CCN3)cc1-c1ccc(S(=O)(=O)N(C)C)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 O14757 3/20 0.38
▸ ATR Q13535 3/20 0.38
▸ PIK3CA P42336 2/20 0.38
▸ NMT1 P30419 2/20 0.34
▸ IKBKB O14920 3/20 0.33
▸ CHUK O15111 3/20 0.33
▸ ENPP1 P22413 1/20 0.32
▸ AURKB Q96GD4 1/20 0.32
▸ AURKAIP1 Q9NWT8 1/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ GFER P55789 1/20 0.32
▸ EED O75530 1/20 0.32
▸ SUZ12 Q15022 1/20 0.32
▸ EZH2 Q15910 1/20 0.32
▸ CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29540861 0.77 ATR (0.58) CHEK1ATRPIK3CAIKBKBCHUK
SCHEMBL101575 0.77 ATR (0.58) CHEK1ATRPIK3CAIKBKBCHUK
SCHEMBL18599971 0.76 MAPKAPK2 (0.34) CDK2
SCHEMBL8738327 0.72 NNMT (0.35) —
SCHEMBL21974392 0.66 MAPT (0.41) SMN1; SMN2KDM4ENPC1ALDH1A1RAB9A
SCHEMBL15730738 0.64 MKNK1 (0.53) IKBKBCHUKSMN1; SMN2KDM4ENPC1
SCHEMBL13540980 0.61 CLK4 (0.38) —
SCHEMBL12506757 0.60 ROCK2 (0.30) —
SCHEMBL13694518 0.59 KCNH2 (0.44) IKBKBCHUKSMN1; SMN2ALDH1A1
SCHEMBL3411509 0.59 IKBKB (0.75) CHEK1ATRPIK3CAIKBKBCHUK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3184526-A1 PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AS JANUS KINASE INHIBITOR Incyte Holdings Corporation (US) 2017-06-28 — — EP disclosed
Send feedback